Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dialysis dose, membrane type, and anemia control

E W Young1

  • 1University of Michigan and Veterans Affairs Medical Center, Ann Arbor 48105, USA. eyoung@umich.edu

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|January 19, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deviation of light incident at the Brewster angle on a wedged window.

Applied optics·2010
Same author

The sedimentation rate in myocardial infarction.

Pennsylvania medical journal (1928)·2010
Same author

Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study.

Kidney international·2006
Same author

Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS.

Kidney international·2006
Same author

[Dialysis Outcomes and Practice Patterns Study: data on the use of central venous catheters in chronic hemodialysis].

Nephrologie·2002
Same author

Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2001

Erythropoietin treatment improves outcomes for dialysis patients with end-stage renal disease (ESRD). Optimal response depends on dialysis dose and dialyzer type, with synthetic membranes potentially enhancing erythropoietin effectiveness.

Area of Science:

  • Nephrology
  • Hematology

Background:

  • Erythropoietin is crucial for treating end-stage renal disease (ESRD) patients.
  • It improves clinical outcomes by increasing red blood cell mass in dialysis patients.
  • However, many patients do not achieve target hematocrit levels, showing variable response to erythropoietin.

Purpose of the Study:

  • To review factors influencing erythropoietin response in ESRD patients.
  • To explore the role of dialysis dose and dialyzer type on erythropoietin effectiveness.
  • To identify modifiable factors for optimizing anemia management in dialysis.

Main Methods:

  • Review of existing literature on erythropoietin therapy in ESRD.
  • Analysis of factors affecting patient response to erythropoietin.
  • Examination of the impact of dialysis parameters on hematocrit levels.

Related Experiment Videos

Main Results:

  • Higher delivered dialysis dose may improve erythropoietin response.
  • Preliminary data suggest synthetic dialyzers may lead to higher hematocrit levels compared to nonsynthetic ones.
  • Significant variation exists in erythropoietin dosage requirements among patients.

Conclusions:

  • Dialysis dose and dialyzer type are potentially modifiable factors influencing erythropoietin response.
  • Optimizing these factors may help achieve target hematocrit goals in ESRD patients.
  • Further research is needed to fully elucidate these relationships for improved patient care.